XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.3

EARNINGS (LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2025

Earnings Per Share [Abstract]

Schedule of calculation of earnings (loss) per share

Earnings (loss) per share attributable to Bausch Health Companies Inc. is calculated as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in millions, except per share amounts)			2025						2024						2025						2024
Net income (loss) attributable to Bausch Health Companies Inc.			$	179					$	(85)					$	269					$	(139)
Basic weighted-average common shares outstanding			371.3						368.4						370.6						367.7
Diluted effect of stock options and RSUs			4.2						—						3.5						—
Diluted weighted-average common shares outstanding			375.5						368.4						374.1						367.7
Earnings (loss) per share attributable to Bausch Health Companies Inc.
Basic			$	0.48					$	(0.23)					$	0.73					$	(0.38)
Diluted			$	0.48					$	(0.23)					$	0.72					$	(0.38)

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration